Shuai Han

Shuai Han


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Acta Tropica
Verified
Journal Article
Open access
MFMei-Hua Fu
Mei-Hua Fu
XWXu Wang
Xu Wang
SHShuai Han
Shuai Han
GYGuan Yayi
Guan Yayi
RBRobert Bergquist
Robert Bergquist
WWWei-Ping Wu
Wei-Ping Wu
Echinococcoses are serious zoonotic diseases in China's vast, western and north-western pastoral areas that has one of the highest prevalence in the world. The two most common forms, cystic echinococcosis (CE) and alveolar echinococcosis (AE), are co-epidemic in some areas causing a grave threat to people's health and economic development. Echinococcus spp. are transmitted through domestic, sylvatic and mixed cycles involving many kinds of host. Successful transmission requires a favourable environment for the growth of the parasites and survival of their eggs, while the unique customs and religious beliefs in the endemic areas pose a challenge to the prevention and control of these parasites. Based on previous epidemiological studies, this paper reviews the particular factors affecting the transmission of Echinococcus parasites in China, with a focus on biological (parasite genotype and the species, age, sex and density of hosts), environmental (landscape and climate) and social (age, gender, ethnicity, education, occupation, life style, cultural customs, living conditions and hygiene practices of humans in the endemic areas). These three factors interact with each other and jointly determine the parasites' transmission intensity, the study of which supports the formulation of the strategies and measures that are significant for control of these infections.

14 February 2025 in Journal of Infection
Verified
Journal Article
Open access
XWXu Wang
Xu Wang
YKYan Kui
Yan Kui
CXChui-Zhao Xue
Chui-Zhao Xue
QWQian Wang
Qian Wang
CZCan-Jun Zheng
Can-Jun Zheng
JCJianping Cao
Jianping Cao
We evaluated the epidemiological characteristics of echinococcosis, a global public health threat, in China to inform global control efforts. Descriptive, statistical, cluster, spatial, and trend analyses were used to evaluate the epidemiology at national, provincial, and county levels based on 2004-2022 nationwide surveillance data from China. Between 2004 and 2022, China recorded 72,676 cystic echinococcosis (CE) cases, 11,465 alveolar echinococcosis (AE) cases, and 5703 others, with an average annual cases per million (ANpM) of 3.45. Females had a higher incidence (ANpM = 3.87) than males (3.05), with most cases (41.15%) in the 30-49 age group, mainly among herders (38.76%) and farmers (37.82%). Seven provinces (Xizang, Qinghai, Xinjiang, Ningxia, Gansu, Sichuan, and Inner Mongolia) accounted for 98.12% of cases, with the Tibetan Plateau showing the highest rates (ANpMs = 155.51 for CE, 46.95 for AE). Surgery and case fatality rates were 39.45% and 5.23% in key surveillance regions (KSRs). Prevalence among residents (0.20%), livestock (1.33%), rodents (1.30%), and dogs (1.26%) declined with increased control funding in KSRs. Between 2023 and 2030, there will be an estimated 20,096 new cases and 45,323 cases requiring treatment. The prevalence of echinococcosis has been alleviated in China, but significant control challenges remain, requiring sustained and targeted control measures.

1 January 2024 in China CDC Weekly
Verified
Journal Article
Open access
PDF file
YKYan Kui
Yan Kui
SHShuai Han
Shuai Han
XZXiaojuan Zhang
Xiaojuan Zhang
GSGuangzhong Shi
Guangzhong Shi
YYYale Yu
Yale Yu
JXJingbo Xue
Jingbo Xue
What is already known about this topic? Echinococcosis is classified as a Class C infectious disease in China. It is endemic in 370 counties located in the agricultural and pastoral regions of western China. What is added by this report? This report provides a comprehensive overview of the cases of echinococcosis reported in China in 2022. Following a thorough evaluation conducted by provincial CDCs, it was identified that 105 new cases were not reported through the National Notifiable Disease Reporting System. Furthermore, there were 1,051 cases that were reported among patients who had been previously diagnosed with echinococcosis. What are the implications for public health practice? The reported cases of echinococcosis in non-endemic counties of provincial-level administrative divisions where the disease is endemic need to be given more attention, as there is a potential risk of it spreading within the non-endemic areas. Inadequate reporting practices by clinical medical institutions are hindering the subsequent investigations carried out by CDCs. It is important to implement enhanced health promotion efforts that focus on high-risk populations to address unhealthy lifestyles.

1 January 2021 in China CDC Weekly
Verified
Journal Article
Open access
PDF file
YKYan Kui
Yan Kui
BLBaixue Liu
Baixue Liu
XWXu Wang
Xu Wang
CXCuizhao Xue
Cuizhao Xue
JXJingbo Xue
Jingbo Xue
WWWeiping Wu
Weiping Wu
What is already known about this topic? Echinococcosis, also known as hydatid disease, is a zoonotic parasitic disease caused by the larvae of Echinococcus granulosus. Western China has one of the most severe epidemics worldwide. Echinococcosis is endemic in 370 counties of 9 provincial-level administrative divisions (PLADs) including Inner Mongolia, Sichuan, Yunnan, Tibet, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang and Xinjiang Production and Construction Corps (XPCC). What is added by this report? From 2017 to 2020, 244 cases were reported in 21 non-endemic PLADs. Of the cases reported in non-endemic PLADs, the majority were imported from endemic areas. Cases reported from non-endemic PLADs have been sporadic, and the number has increased in some areas. What are the implications for public health practice? Migrant workers and livestock from endemic areas may have contributed to the increased incidence of locally acquired infections in non-endemic PLADs, suggesting that health education among workers and livestock quarantine is important for the control of spread in non-endemic PLADs.

3 December 2018 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
SHShuai Han
Shuai Han
WWWei-Ping Wu
Wei-Ping Wu
KCKai Chen
Kai Chen
IOIsrayil Osman
Israyil Osman
KKKaisar Kiyim
Kaisar Kiyim
CZCan-Jun Zheng
Can-Jun Zheng
Leishmania parasites cause visceral leishmaniasis (VL), an important infectious disease that is endemic to large parts of the world and often leads to epidemics. Sand flies are the primary transmission vector for the parasite in endemic regions. We hypothesized that sheep might serve as an overlooked reservoir for Leishmania transmission to humans due to the asymptomatic nature of infection in many species. As a preliminary test of this hypothesis, the aim of the present study was to investigate sheep in an area of China that is endemic for the desert sub-type of zoonotic VL and establish if they are potential carriers of Leishmania. Sheep tissue samples were collected from abattoirs in VL endemic areas of Jiashi County, China during the non-transmission season. rK39 immunochromatographic tests were performed to detect the presence of the parasite in blood samples. In addition, DNA was extracted from the blood, and used for detection of the Leishmania-specific internal transcribed spacer-1 (ITS-1) genomic region using a nested polymerase chain reaction (PCR) approach. PCR products were further analyzed to identify restriction fragment-length polymorphism patterns and representative sequences of each pattern were selected for phylogenetic analysis. The rK-39 and nested PCR data indicated positive detection rates for Leishmania in sheep of 26.32 and 54.39%, respectively. The phylogenetic analysis revealed that all of the samples belonged to the species L. infantum and were closely related to strains isolated from human infections in the same area. Sheep could be a potential host for Leishmania in VL endemic areas in China and may be an overlooked reservoir of human VL transmission in this region. To further confirm livestock as a potential host, further verification is required using a sand fly biting experiment.

24 July 2025 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
XWXu Wang
Xu Wang
ZXZhan-Jun Xiao
Zhan-Jun Xiao
CXChui-Zhao Xue
Chui-Zhao Xue
WWWen-Ting Wu
Wen-Ting Wu
JYJiang-Hui Yang
Jiang-Hui Yang
SLShizhu Li
Shizhu Li
Background: Alveolar echinococcosis (AE), caused by the larval stage of Echinococcus multilocularis, poses a substantial global health challenge due to its high mortality profile. This study reports the inaugural human infection of echinococcosis caused by the Mongolian genotype of E. multilocularis in China, also the first reported indigenous AE case in Inner Mongolia. Case presentation: A 58-year-old female pastoralist from Inner Mongolia, who had no endemic region exposure history but prolonged occupational contact with dogs, presented with severe AE. Clinical examinations revealed a massive hepatic lesion exceeding 10 cm in diameter, accompanied by elevated eosinophils (0.90 × 109/L) and basophils (0.08 × 109/L). Despite undergoing liver transplantation, the patient succumbed postoperatively. Histopathological confirmation and molecular phylogenetics identified the Mongolian genotype of E. multilocularis infection, distinct from the predominant Asian genotype in China. Potential evidence of zoonotic transmission was discovered through genotype-matched E. multilocularis detection in corsac fox (Vulpes corsac) feces from the grasslands along the shores of Hulun Lake (Hulun Buir City, northeastern Inner Mongolia, China). Conclusions: This report provides the primary evidence of a locally acquired human AE infection in China caused by the Mongolian genotype of Echinococcus multilocularis. The discovery of this case challenges historical classifications of echinococcosis endemic areas. The findings call for revised AE-endemic identification criteria, improved AE diagnostic protocols, and enhanced AE surveillance in the Inner Mongolia region to generate further epidemiological evidence and information on disease progression.